Search Medical Condition
Please enter condition
Please choose location

Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (506) clinical trials

A study of an investigational treatment in patients with anal fissures. REF: x41

Phase

A research study is evaluating an investigational medication for Nonalcoholic Fatty Liver Disease (NAFLD).

Phase N/A

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Study Evaluating the Safety and Efficacy of Obeticholic Acid (study medication) in Subjects with Nonalcoholic Steatohepatitis (NASH).

Phase

A Randomized, Double-Blind, Parallel-Group Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 (Study Medication) compared to Placebo in Subjects with Chronic Pancreatitis.

Phase N/A

People with Cystic Fibrosis are invited to participate in a research study being conducted by Northwell Health, Inc.

Phase N/A

A study testing the safety, tolerability, and effectiveness of a medication for individuals with non-alcoholic steatohepatitis (NASH). REF: x18-CLN

Phase

Data collection on patients with NAFLD/NASH to determine the natural course of the liver disease and to determine if certain lifestyle changes or diet changes that may be recommended by your doctor can affect NAFLD/NASH. Optional blood samples may be collected once a year to identify and understand the genetic ...

Phase N/A

Data collection study to determine if certain lifestyle changes or changes in diet or other treatments that may be recommended by your doctors can affect PBC. Researchers are interested in observing how these lifestyle changes, counseling, or other treatments work in patients who are treated by their doctors in routine ...

Phase N/A

Children who have Fatty Liver Disease are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for patients with non-alcoholic fatty liver disease accompanied by high cholesterol. Qualified participants receive study-related medical care from a board-certified physician, study medications, exams and evaluations.

Phase